Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

Evaluation and management of longitudinally extensive transverse myelitis: a guide for radiologists.
US health insurance is an obstacle to disease-modifying treatments in MS.
Hereditary and metabolic myelopathies.
Astrocyte-Microglia Cross Talk through Complement Activation Modulates Amyloid Pathology in Mouse Models of Alzheimer's Disease.
A novel highly selective 5-HT6 receptor antagonist attenuates ethanol and nicotine seeking but does not affect inhibitory response control in Wistar rats.
Th1, Th2 and Th17 Cytokine Profile in Patients with Multiple Sclerosis Following Treatment with Rapamycin.
Simultaneous Complement Response via Lectin Pathway in Retina and Optic Nerve in an Experimental Autoimmune Glaucoma Model.
Monoclonal Antibody Therapy for Neuromyelitis Optica Spectrum Disorder: Current and Future.
Can we stop immunomodulatory treatments in secondary progressive multiple sclerosis?
Pembrolizumab-Induced Demyelinating Polyradiculoneuropathy.
Development and Feasibility of an Evidence-Based Patient Education Program for Managing Fatigue in Multiple Sclerosis: The "Fatigue Management in MS" Program (FatiMa).
Individual Differences in the Alignment of Structural and Functional Markers of the V5/MT Complex in Primates.
HIV-1 Tat Inhibits Autotaxin Lysophospholipase D Activity and Modulates Oligodendrocyte Differentiation.
Comparison of Personal Resources in Patients Who Differently Estimate the Impact of Multiple Sclerosis.
Cognitive impairment and magnetic resonance imaging correlates in primary progressive multiple sclerosis.
Corrigendum.
Atypical parkinsonism in C9orf72 expansions: a case report and systematic review of 45 cases from the literature.
The MS Center of Saint Louis: a practice perspective of the impacts of high cost sharing.
Functional Brain Network Alterations in Clinically Isolated Syndrome and Multiple Sclerosis: A Graph-based Connectome Study.
Drinking away fatigue in multiple sclerosis.
Evaluation of the Expanded Disability Status Scale and the Multiple Sclerosis Functional Composite as clinical endpoints in multiple sclerosis clinical trials: quantitative meta-analyses.
A Microsoft Kinect-Based Point-of-Care Gait Assessment Framework for Multiple Sclerosis Patients.
IL-10 Modulates Th17 Pathogenicity during Autoimmune Diseases.
Is There an Increased Risk for Ischemic Stroke in Patients with Multiple Sclerosis, and If So, Should Preventive Treatment Be Considered?
Sobetirome prodrug esters with enhanced blood-brain barrier permeability.

Pages